... — Scientific American
Homepage— ClinicalTrials.gov
Semaglutide’s Efficacy in Achieving Weight Loss for Those With HIV (SWIFT) — ClinicalTrial.gov
Effects of Semaglutide in HIV-Associated Lipohypertrophy — ClinicalTrials.gov
Famous Weight Loss Drug May Help People With HIV Get Healthier, MUSC Researcher Says — Medical University of South Carolina ...
Los análogos del GLP-1 y el VIH: ¿se pueden tomar con sus medicamentos sin riesgos?
... — Scientific American
Homepage— ClinicalTrials.gov
Semaglutide’s Efficacy in Achieving Weight Loss for Those With HIV (SWIFT) — ClinicalTrial.gov
Effects of Semaglutide in HIV-Associated Lipohypertrophy — ClinicalTrials.gov
Famous Weight Loss Drug May Help People With HIV Get Healthier, MUSC Researcher Says — Medical University of South Carolina ...
... -2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral Hepatitis
Epidemiological Trends of HIV/HCV Coinfection in Spain, 2015-2019 — HIV Medicine ...
Envejecer con VIH: 5 problemas que debe vigilar
... -2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral Hepatitis
Epidemiological Trends of HIV/HCV Coinfection in Spain, 2015-2019 — HIV Medicine ...
... Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting — Cannabis and Cannabinoid Research
Cannabidiol (CBD) in Cancer Management — Cancers
Anxiety — Medical Cannabis and CBD in Mental Healthcare
Cannabidiol Adverse Effects and Toxicity — Current Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With ...
CBD para el VIH: ¿es eficaz?
... Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting — Cannabis and Cannabinoid Research
Cannabidiol (CBD) in Cancer Management — Cancers
Anxiety — Medical Cannabis and CBD in Mental Healthcare
Cannabidiol Adverse Effects and Toxicity — Current Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With ...
... Sleep: A Review of the Literature — Current Psychiatry Reports
Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression — Sleep
Cannabidiol in Anxiety and Sleep: A Large Case Series — The Permanente Journal
Sleep Deficiency and Chronic Pain: Potential Underlying Mechanisms and Clinical Implications — Neuropsychopharmacology
Cannabis-Based ...
Marihuana médica y VIH: ¿puede ayudar?
... Sleep: A Review of the Literature — Current Psychiatry Reports
Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression — Sleep
Cannabidiol in Anxiety and Sleep: A Large Case Series — The Permanente Journal
Sleep Deficiency and Chronic Pain: Potential Underlying Mechanisms and Clinical Implications — Neuropsychopharmacology
Cannabis-Based ...
... El periodo de ventana —es decir, el tiempo que debe pasar para que la prueba pueda detectar la infección con precisión— va de los 23 a los 90 días después del contagio.Si su prueba de anticuerpos sale no reactiva, significa que no se detectaron anticuerpos del VIH en su muestra de sangre.Esta prueba podría no detectar el VIH con precisión si se la realiza ...
¿Qué significa un resultado no reactivo en la prueba del VIH? Entienda sus resultados
... El periodo de ventana —es decir, el tiempo que debe pasar para que la prueba pueda detectar la infección con precisión— va de los 23 a los 90 días después del contagio.Si su prueba de anticuerpos sale no reactiva, significa que no se detectaron anticuerpos del VIH en su muestra de sangre.Esta prueba podría no detectar el VIH con precisión si se la realiza ...
... tratamiento del VIH — HIVinfo.NIH.gov
Antiretroviral Therapy — Cleveland Clinic
HIV Resistance Testing — International Association of Providers of AIDS Care
HIV Drug Resistance — World Health Organization
Virologic Failure — HIVinfo.NIH.gov
HIV Drug Resistance — HIVinfo.NIH.gov
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With ...
Resistencia farmacológica al VIH: Mutaciones, pruebas, síntomas, y más
... tratamiento del VIH — HIVinfo.NIH.gov
Antiretroviral Therapy — Cleveland Clinic
HIV Resistance Testing — International Association of Providers of AIDS Care
HIV Drug Resistance — World Health Organization
Virologic Failure — HIVinfo.NIH.gov
HIV Drug Resistance — HIVinfo.NIH.gov
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With ...
... Si se realiza una de estas pruebas antes de este período, puede recibir un resultado falso negativo, lo que significa que su prueba será negativa, aunque todavía podría estar infectado con el VIH. ...
... El riesgo aumenta si la persona que realiza el sexo oral tiene otra ITS (como el herpes), o si hay semen en la boca y la persona tiene encías sangrantes, llagas en la boca o úlceras genitales.¿Cómo se pueden prevenir el herpes y el VIH? ...
Herpes vs. VIH: ¿Cuál es la diferencia?
... El riesgo aumenta si la persona que realiza el sexo oral tiene otra ITS (como el herpes), o si hay semen en la boca y la persona tiene encías sangrantes, llagas en la boca o úlceras genitales.¿Cómo se pueden prevenir el herpes y el VIH? ...
... Managing Weight Gain in HIV Patients — European AIDS Treatment Group
Obesity and Weight Gain in Persons With HIV — Current HIV/AIDS Reports
Weight Gain on HIV Treatment: More Common With Newer Drugs, Low CD4 Counts — NAM aidsmap ...
4 causas de aumento de peso con el VIH
... Managing Weight Gain in HIV Patients — European AIDS Treatment Group
Obesity and Weight Gain in Persons With HIV — Current HIV/AIDS Reports
Weight Gain on HIV Treatment: More Common With Newer Drugs, Low CD4 Counts — NAM aidsmap ...
... Sleep — Mayo Clinic
Myths and Facts About Sleep — Sleep Foundation
Fatigue Is Associated With Worse Cognitive and Everyday Functioning in Older Persons With HIV — AIDS ...
únete
